Physicians at Temple have a wealth of experience treating asthma patients with both established and cutting edge medications such as Xolair, Nucala, and Cinqair. Doctors at the Airway Disorders Program are also involved in clinical trials that evaluate new and promising asthma medications, including Gleevec, benralizumab, and tralokinumab. Patients who fit trial criteria may have access to new therapies before they are approved by the FDA through Temple’s extensive clinical trial program. Temple’s Airway Disorders Program also offers bronchial thermoplasty treatment to appropriate patients, which can significantly improve quality of life and breathing function.
Physicians at Temple are also adept at airway stenting, cryotherapy, laser therapy, and advanced surgical procedures needed to treat challenging airway issues.